Oragenics, Inc.
OGEN · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $73,372 | $380,025 | $380,063 | $1,510,865 |
| - Cash | $865 | $3,484 | $11,427 | $27,266 |
| + Debt | $329 | $323 | $625 | $797 |
| Enterprise Value | $72,835 | $376,864 | $369,260 | $1,484,396 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10,538 | -$20,598 | -$14,229 | -$15,655 |
| % Margin | – | – | – | – |
| Net Income | -$10,568 | -$20,656 | -$14,288 | -$15,712 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.6 | -9.18 | -7.11 | -8.09 |
| % Growth | 82.6% | -29.1% | 12.1% | – |
| Operating Cash Flow | -$8,597 | -$7,291 | -$15,228 | -$13,470 |
| Capital Expenditures | $0 | -$1,000 | -$128 | -$44 |
| Free Cash Flow | -$8,597 | -$8,291 | -$15,356 | -$13,514 |